Myelopreservation With Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results From a Randomized, Double-Blind, Placebo-Controlled Phase II Study
figure
posted on 2020-10-23, 12:28 authored by Lowell L. Hart, Renata Ferrarotto, Zoran G. Andric, J. Thaddeus Beck, Janakiraman Subramanian, Davorin Z. Radosavljevic, Bojan Zaric, Wahid T. Hanna, Raid Aljumaily, Taofeek K. Owonikoko, Didier Verhoeven, Jie Xiao, Shannon R. Morris, Joyce M. Antal, Maen A. HusseinThe above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
